Merged into 4D pharma PLC, ticker now LBPS
LOAC

Completed

4D pharma PLC

Longevity Acquisition Corp

External link: SEC Filings

SPAC Team

Leadership

Matthew Chen has served as our Chairman and Chief Executive Officer since June 2018. Since January 2018, Mr. Chen has served as Vice President of XiaoMingTaiJi Anime Limited Co., where Mr. Chen is mainly responsible for equity investment, acquisitions and corporate financing. From 2011 to January 2018, Mr. Chen served as the global head of the credit derivative market making platform at JP Morgan’s London branch. From 2008 to 2011, Mr. Chen served as the Asia credit derivative risk analysis manager at JP Morgan’s Hong Kong branch. From 2005 to 2008, Mr. Chen served as Managing Director at Bear Stearns, responsible for the firm’s equity derivative strategic product development. From 2003 to 2005, Mr. Chen served as Vice President at Realty Data Corp. an independent mortgage data provider. From 1998 to 2003, Mr. Chen served as Senior Manager at Imagine Software, a quantitative financial model provider. Mr. Chen holds a BS from Florida State University and MS Degree of Computer Science from New York University. We believe Mr. Chen is qualified to serve as a director because of his extensive financial and operations experience and the extensive network he has established throughout his career.

Teddy Zheng has served as our Chief Financial Officer since July 2018. Mr. Zheng has served as executive director of Cyngus Equity, an investment and financial advisory firm in China, since October 2015. From April 2014 to October 2015, Mr. Zheng worked in the investment banking division of Lazard in China. From November 2010 to March 2014, Mr. Zheng worked in the investment banking division of JPMorgan First Capital in China. From June 2009 to October 2010, Mr. Zheng worked in the M&A and corporate finance division of UBS Investment Bank in China. Mr. Zheng received a bachelor degree in management information systems from Beijing Information Technology Institute and a master degree in management science and engineering from the School of Economics and Management of Tsinghua University.

Feng Peng is a member of our board of directors as of the date hereof. Mr. Peng has served as managing partner of Linden Rose Investment LLC since January 2017, where he manages assets for multi-family offices. Mr. Peng has also served as a director of USANA Health Sciences, Inc. since 2016. From March 2013 to December 2016, Mr. Peng served as the Chief Financial Officer of Ossen Innovation Co., Ltd. (Nasdaq: OSN). Mr. Peng served as Senior Vice President at MZ Group from August 2007 until September 2012. Prior to working at MZ Group, he served in various capacities at Thomson Financial and Citigroup. Mr. Peng graduated from New Jersey Institute of Technology in Computer Science, earning a Master of Science degree. Mr. Peng earned a bachelor’s degree in Automation Control from Shanghai Jiao Tong University in Shanghai, China. Mr. Peng is certified Senior International Finance Manager (SIFM) in China. We believe Mr. Peng is qualified to serve as a director because of his extensive financial and operations experience and the extensive network he has established throughout his career.

Jun Liu is a member of our board of directors as of the date hereof. Mr. Liu has served as the president of Beijing Wanfeng Xingye Investment Management Co., Ltd., an investment company in China, since January 2014. From 2004 to January 2014, he served as the president of Zhongansheng Investment Consulting Co, Ltd. From 2002 to 2004, Mr. Liu served as the vice president of Beijing Xingyun Co., Ltd. From 1999 to 2002, Mr. Liu served as the CEO of Weixin (China) Venture Investment Co., Ltd. and the director of Venture Capital Research Center of Renmin University. From 1993 to 1996, Mr. Liu served as government official in the State Auditing Administration. Mr. Liu represented Beijing Xingyun in its acquisition transaction by Pepsi twenty years ago. He also advised Xinhua Media on its reverse merger with Zhizhen Tech (HK: 02371). His investment portfolios cover wide range of sectors, including TMT, education, clean energy, technology, and chemical industries. Mr. Liu received his bachelor degree of Finance and Accounting from Wuhan University in 1989 and received his MBA degree from Renmin University China in 1999. We believe Mr. Liu is qualified to serve as a director because of his extensive financial, investment and M&A experience and the extensive network he has established throughout his career.

Jason Zhang is a member of our board of directors as of the date hereof. Mr. Zhang has been managing several growth equity funds in China, including Ccin Capital Investment (Zhuhai) Corp. since June 2018, Ebula Investment Fund since December 2017, Blue Stone Capital since March 2015 and Mingen Capital since March 2013. Mr. Zhang has also served as Managing Director of SBI Financial Holding Group China since January 2017. Mr. Zhang has specialized in equity and debt financing for public private partnership projects, including infrastructure projects and characteristic town projects recently promoted by the Chinese government. From 2007 to 2012, Mr. Zhang founded and operated three start-up internet commerce companies: Seven Day Ecommerce Co., Ltd, New Dream Technology Co., Ltd. and Weipin Industries Co., Ltd. Mr. Zhang received his MBA degree from Zhejiang University. We believe Mr. Zhang is qualified to serve as a director because of his extensive financial, investment experience and the extensive network he has established throughout his career.

Advisor

Bill Huo, our advisor since our inception, serves in a non-executive capacity on behalf of our company, in connection with legal and business development matters. Mr. Huo has served as counsel of the law firm Ellenoff Grossman & Schole LLP, our legal counsel, since April 2014. Mr. Huo’s corporate and securities law practices concentrate on cross-border corporate finance, merger and acquisition transactions and general corporate advice. Mr. Huo has advised Chinese clients with respect to initial public offerings, financings and M&A transactions. In addition, Mr. Huo has counseled U.S. companies transacting business in and related to China. Previously, Mr. Huo was an associate at the law firm Kramer Levin Naftalis & Frankel LLP from 2006 to 2013. Before that, Mr. Huo served as legal counsel of China Resources Corporation, a Fortune 500 conglomerate company based in Hong Kong and China. Mr. Huo received a LLM degree from Cornell Law School, a LLM degree from the University of Bristol and a LLM degree from Renmin University in 1998.